Cisiv launches Baseline Plus for "real world" trials

By Gareth Macdonald

- Last updated on GMT

Related tags: Clinical research

UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials.

Observational, or post-market studies, differ from clinical trials in that they are, by definition, non-interventional and often involve a greater number of patients and physicians over a wide area.

As a result, electronic data capture (EDC) methods developed for clinical trials are often to complex to be a practical option for “real world” situations and non-specialist operators.

Outsourcing-pharma spoke with Dominic Farmer, Cisiv CEO, about how the new Baseline Plus system can help overcome such problems and how the software fits into the growing pharmaceutical industry market for post-approval observational analysis.

Related topics: Processing equipment

Related news

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers